Un nuevo rival de Wegovy se muestra promisorio en ensayos clínicos
MARTES, 27 de junio de 2023 (HealthDay News) — Un medicamento experimental parece funcionar mejor que los medicamentos de moda, Wegovy y Ozempic, tanto para perder peso como para controlar la diabetes, muestran dos ensayos clínicos iniciales. La reta…
Learn MoreIs Coffee’s Morning Jolt Mostly Placebo?
WEDNESDAY, June 28, 2023 (HealthDay News) — Coffee kickstarts many a sleepyhead’s day, but a new study argues that it’s not the caffeine alone that provides the morning wake-up.People who took a basic caffeine pill did not experience the same sort of…
Learn MoreUnos nuevos fármacos para perder peso se preparan para competir con Ozempic y Wegovy
LUNES, 26 de junio de 2023 (HealthDay News) — Después de que la compañía farmacéutica Novo Nordisk modificara su medicamento Ozempic para convertirlo en Wegovy, una formulación diseñada de forma expresa para ayudar a los usuarios a bajar de peso, las…
Learn MoreTomar complementos de cetonas para mejorar el desempeño deportivo puede ser contraproducente
LUNES, 26 de junio de 2023 (HealthDay News) — Los deportistas que usan complementos de cetonas para mejorar su desempeño quizá no se estén haciendo ningún favor, advierten unos investigadores. La literatura sobre los beneficios de los complementos de…
Learn MoreADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D
TUESDAY, June 27, 2023 (HealthDay News) — Once-weekly tirzepatide provides substantial and clinically meaningful reductions in body weight in adults with obesity and type 2 diabetes, according to a study published online June 26 in the The Lancet to …
Learn MoreADA: Once-Daily Semaglutide Superior for Reduction in Body Weight
TUESDAY, June 27, 2023 (HealthDay News) — Oral semaglutide 50 mg once daily leads to a superior and clinically meaningful reduction in body weight for adults with overweight or obesity without type 2 diabetes, according to a study published online Ju…
Learn MoreNew Competitor to Wegovy Shows Promise in Clinical Trials
TUESDAY, June 27, 2023 (HealthDay News) — An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows.Retatrutide helped people with obesity dro…
Learn MoreFasting Diets vs. Cutting Calories: Which Works Best?
TUESDAY, June 27, 2023 (HealthDay News) — A trendy form of intermittent fasting does seem to help people lose some weight — though it may be no better than old-fashioned calorie counting, a new clinical trial suggests.Researchers found that the tacti…
Learn MoreWeight-Loss Surgery Can Keep Diabetes at Bay for Years: Study
TUESDAY, June 27, 2023 (HealthDay News) — Gastric bypass surgery is a potential long-term cure for type 2 diabetes, especially if the procedure is performed before the disease progresses, a new study argues.Among a large group of obese people with ty…
Learn More